The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?

Purpose To compare the efficacy and perioperative complications of the AdVanceXP with the original AdVance male sling. Methods We retrospectively enrolled 109 patients with an AdVance and 185 patients with an AdVanceXP male sling. The baseline characteristics and complication rates were analyzed ret...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of urology 2018-10, Vol.36 (10), p.1657-1662
Hauptverfasser: Hüsch, Tanja, Kretschmer, Alexander, Thomsen, Frauke, Kronlachner, Dominik, Kurosch, Martin, Obaje, Alice, Anding, Ralf, Kirschner-Hermanns, Ruth, Pottek, Tobias, Rose, Achim, Olianas, Roberto, Lusuardi, Lukas, Friedl, Alexander, Homberg, Roland, Pfitzenmaier, Jesco, Queissert, Fabian, Naumann, Carsten M., Schweiger, Josef, Wotzka, Carola, Nyarangi-Dix, Joanne, Brehmer, Bernhard, Abdunnur, Rudi, Loertzer, Hagen, Ulm, Kurt, Hübner, Wilhelm, Bauer, Ricarda M., Haferkamp, Axel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1662
container_issue 10
container_start_page 1657
container_title World journal of urology
container_volume 36
creator Hüsch, Tanja
Kretschmer, Alexander
Thomsen, Frauke
Kronlachner, Dominik
Kurosch, Martin
Obaje, Alice
Anding, Ralf
Kirschner-Hermanns, Ruth
Pottek, Tobias
Rose, Achim
Olianas, Roberto
Lusuardi, Lukas
Friedl, Alexander
Homberg, Roland
Pfitzenmaier, Jesco
Queissert, Fabian
Naumann, Carsten M.
Schweiger, Josef
Wotzka, Carola
Nyarangi-Dix, Joanne
Brehmer, Bernhard
Abdunnur, Rudi
Loertzer, Hagen
Ulm, Kurt
Hübner, Wilhelm
Bauer, Ricarda M.
Haferkamp, Axel
description Purpose To compare the efficacy and perioperative complications of the AdVanceXP with the original AdVance male sling. Methods We retrospectively enrolled 109 patients with an AdVance and 185 patients with an AdVanceXP male sling. The baseline characteristics and complication rates were analyzed retrospectively. Functional outcome and quality of life were evaluated prospectively by standardized, validated questionnaires. The Chi 2 -test for categorical and Mann–Whitney U test for continuous variables were performed to identify heterogeneity between the groups. Results Regarding operation time, there was no significant difference between the slings ( p  = 0.146). The complication rates were comparable in both groups except for postoperative urinary retention. This occurred significantly more often in patients with the AdVanceXP ( p  = 0.042). During follow-up, no differences could be identified regarding ICIQ-SF, PGI or I-QoL or number of pad usage. Conclusions The AdVance and AdVanceXP are safe and effective treatment options for male stress urinary incontinence. However, the innovations of the AdVanceXP sling did not demonstrate a superiority over the original AdVance sling regarding functional outcome.
doi_str_mv 10.1007/s00345-018-2316-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2035242476</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2035242476</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-697443928861c8abcbc1f0c241ed8108aee4622f017e7ff9eae813c30506b6423</originalsourceid><addsrcrecordid>eNp1kEFLJDEQhYOs6Kz6A7xI2JOXXiuVdJLei4joriDoYRRvIZOu1paetCbTB_-9kdEVBE95JN97VXmM7Qv4LQDMUQaQqq5A2Aql0FW9wWZCSVlZg_oHm4FBVanGym32M-dHAGE01FtsGxuD1mg1Y_P5A_GT9tbHQNzH9kPfXfOlH4jnoY_3vI98Sn306aXIMMZVH6lAf3if-eqBUrHytu-6osr18S7b7PyQae_93GE352fz03_V5dXfi9OTyypII1aVboxSskFrtQjWL8IiiA4CKkGtFWA9kdKIXVmbTNc15MkKGSTUoBdaodxhh-vcpzQ-T5RXbtnnQMPgI41TdgiyRoXK6IL--oI-jlOKZTuHCGjqRjQFEmsopDHnRJ17Sv2y_NoJcG-Nu3XjrjTu3hp3dfEcvAdPiyW1_x0fFRcA10AuT_Ge0ufk71NfAUlDiRs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>220275919</pqid></control><display><type>article</type><title>The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Hüsch, Tanja ; Kretschmer, Alexander ; Thomsen, Frauke ; Kronlachner, Dominik ; Kurosch, Martin ; Obaje, Alice ; Anding, Ralf ; Kirschner-Hermanns, Ruth ; Pottek, Tobias ; Rose, Achim ; Olianas, Roberto ; Lusuardi, Lukas ; Friedl, Alexander ; Homberg, Roland ; Pfitzenmaier, Jesco ; Queissert, Fabian ; Naumann, Carsten M. ; Schweiger, Josef ; Wotzka, Carola ; Nyarangi-Dix, Joanne ; Brehmer, Bernhard ; Abdunnur, Rudi ; Loertzer, Hagen ; Ulm, Kurt ; Hübner, Wilhelm ; Bauer, Ricarda M. ; Haferkamp, Axel</creator><creatorcontrib>Hüsch, Tanja ; Kretschmer, Alexander ; Thomsen, Frauke ; Kronlachner, Dominik ; Kurosch, Martin ; Obaje, Alice ; Anding, Ralf ; Kirschner-Hermanns, Ruth ; Pottek, Tobias ; Rose, Achim ; Olianas, Roberto ; Lusuardi, Lukas ; Friedl, Alexander ; Homberg, Roland ; Pfitzenmaier, Jesco ; Queissert, Fabian ; Naumann, Carsten M. ; Schweiger, Josef ; Wotzka, Carola ; Nyarangi-Dix, Joanne ; Brehmer, Bernhard ; Abdunnur, Rudi ; Loertzer, Hagen ; Ulm, Kurt ; Hübner, Wilhelm ; Bauer, Ricarda M. ; Haferkamp, Axel</creatorcontrib><description>Purpose To compare the efficacy and perioperative complications of the AdVanceXP with the original AdVance male sling. Methods We retrospectively enrolled 109 patients with an AdVance and 185 patients with an AdVanceXP male sling. The baseline characteristics and complication rates were analyzed retrospectively. Functional outcome and quality of life were evaluated prospectively by standardized, validated questionnaires. The Chi 2 -test for categorical and Mann–Whitney U test for continuous variables were performed to identify heterogeneity between the groups. Results Regarding operation time, there was no significant difference between the slings ( p  = 0.146). The complication rates were comparable in both groups except for postoperative urinary retention. This occurred significantly more often in patients with the AdVanceXP ( p  = 0.042). During follow-up, no differences could be identified regarding ICIQ-SF, PGI or I-QoL or number of pad usage. Conclusions The AdVance and AdVanceXP are safe and effective treatment options for male stress urinary incontinence. However, the innovations of the AdVanceXP sling did not demonstrate a superiority over the original AdVance sling regarding functional outcome.</description><identifier>ISSN: 0724-4983</identifier><identifier>EISSN: 1433-8726</identifier><identifier>DOI: 10.1007/s00345-018-2316-5</identifier><identifier>PMID: 29728764</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Aged ; Chi-Square Distribution ; Follow-Up Studies ; Humans ; Male ; Medicine ; Medicine &amp; Public Health ; Nephrology ; Oncology ; Operative Time ; Original Article ; Patients ; Prospective Studies ; Quality of Life ; Retrospective Studies ; Suburethral Slings - adverse effects ; Suburethral Slings - classification ; Treatment Outcome ; Urinary incontinence ; Urinary Incontinence, Stress - therapy ; Urology</subject><ispartof>World journal of urology, 2018-10, Vol.36 (10), p.1657-1662</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2018</rights><rights>World Journal of Urology is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-697443928861c8abcbc1f0c241ed8108aee4622f017e7ff9eae813c30506b6423</citedby><cites>FETCH-LOGICAL-c371t-697443928861c8abcbc1f0c241ed8108aee4622f017e7ff9eae813c30506b6423</cites><orcidid>0000-0002-7872-5496</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00345-018-2316-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00345-018-2316-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,782,786,27931,27932,41495,42564,51326</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29728764$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hüsch, Tanja</creatorcontrib><creatorcontrib>Kretschmer, Alexander</creatorcontrib><creatorcontrib>Thomsen, Frauke</creatorcontrib><creatorcontrib>Kronlachner, Dominik</creatorcontrib><creatorcontrib>Kurosch, Martin</creatorcontrib><creatorcontrib>Obaje, Alice</creatorcontrib><creatorcontrib>Anding, Ralf</creatorcontrib><creatorcontrib>Kirschner-Hermanns, Ruth</creatorcontrib><creatorcontrib>Pottek, Tobias</creatorcontrib><creatorcontrib>Rose, Achim</creatorcontrib><creatorcontrib>Olianas, Roberto</creatorcontrib><creatorcontrib>Lusuardi, Lukas</creatorcontrib><creatorcontrib>Friedl, Alexander</creatorcontrib><creatorcontrib>Homberg, Roland</creatorcontrib><creatorcontrib>Pfitzenmaier, Jesco</creatorcontrib><creatorcontrib>Queissert, Fabian</creatorcontrib><creatorcontrib>Naumann, Carsten M.</creatorcontrib><creatorcontrib>Schweiger, Josef</creatorcontrib><creatorcontrib>Wotzka, Carola</creatorcontrib><creatorcontrib>Nyarangi-Dix, Joanne</creatorcontrib><creatorcontrib>Brehmer, Bernhard</creatorcontrib><creatorcontrib>Abdunnur, Rudi</creatorcontrib><creatorcontrib>Loertzer, Hagen</creatorcontrib><creatorcontrib>Ulm, Kurt</creatorcontrib><creatorcontrib>Hübner, Wilhelm</creatorcontrib><creatorcontrib>Bauer, Ricarda M.</creatorcontrib><creatorcontrib>Haferkamp, Axel</creatorcontrib><title>The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?</title><title>World journal of urology</title><addtitle>World J Urol</addtitle><addtitle>World J Urol</addtitle><description>Purpose To compare the efficacy and perioperative complications of the AdVanceXP with the original AdVance male sling. Methods We retrospectively enrolled 109 patients with an AdVance and 185 patients with an AdVanceXP male sling. The baseline characteristics and complication rates were analyzed retrospectively. Functional outcome and quality of life were evaluated prospectively by standardized, validated questionnaires. The Chi 2 -test for categorical and Mann–Whitney U test for continuous variables were performed to identify heterogeneity between the groups. Results Regarding operation time, there was no significant difference between the slings ( p  = 0.146). The complication rates were comparable in both groups except for postoperative urinary retention. This occurred significantly more often in patients with the AdVanceXP ( p  = 0.042). During follow-up, no differences could be identified regarding ICIQ-SF, PGI or I-QoL or number of pad usage. Conclusions The AdVance and AdVanceXP are safe and effective treatment options for male stress urinary incontinence. However, the innovations of the AdVanceXP sling did not demonstrate a superiority over the original AdVance sling regarding functional outcome.</description><subject>Aged</subject><subject>Chi-Square Distribution</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Nephrology</subject><subject>Oncology</subject><subject>Operative Time</subject><subject>Original Article</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Quality of Life</subject><subject>Retrospective Studies</subject><subject>Suburethral Slings - adverse effects</subject><subject>Suburethral Slings - classification</subject><subject>Treatment Outcome</subject><subject>Urinary incontinence</subject><subject>Urinary Incontinence, Stress - therapy</subject><subject>Urology</subject><issn>0724-4983</issn><issn>1433-8726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kEFLJDEQhYOs6Kz6A7xI2JOXXiuVdJLei4joriDoYRRvIZOu1paetCbTB_-9kdEVBE95JN97VXmM7Qv4LQDMUQaQqq5A2Aql0FW9wWZCSVlZg_oHm4FBVanGym32M-dHAGE01FtsGxuD1mg1Y_P5A_GT9tbHQNzH9kPfXfOlH4jnoY_3vI98Sn306aXIMMZVH6lAf3if-eqBUrHytu-6osr18S7b7PyQae_93GE352fz03_V5dXfi9OTyypII1aVboxSskFrtQjWL8IiiA4CKkGtFWA9kdKIXVmbTNc15MkKGSTUoBdaodxhh-vcpzQ-T5RXbtnnQMPgI41TdgiyRoXK6IL--oI-jlOKZTuHCGjqRjQFEmsopDHnRJ17Sv2y_NoJcG-Nu3XjrjTu3hp3dfEcvAdPiyW1_x0fFRcA10AuT_Ge0ufk71NfAUlDiRs</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Hüsch, Tanja</creator><creator>Kretschmer, Alexander</creator><creator>Thomsen, Frauke</creator><creator>Kronlachner, Dominik</creator><creator>Kurosch, Martin</creator><creator>Obaje, Alice</creator><creator>Anding, Ralf</creator><creator>Kirschner-Hermanns, Ruth</creator><creator>Pottek, Tobias</creator><creator>Rose, Achim</creator><creator>Olianas, Roberto</creator><creator>Lusuardi, Lukas</creator><creator>Friedl, Alexander</creator><creator>Homberg, Roland</creator><creator>Pfitzenmaier, Jesco</creator><creator>Queissert, Fabian</creator><creator>Naumann, Carsten M.</creator><creator>Schweiger, Josef</creator><creator>Wotzka, Carola</creator><creator>Nyarangi-Dix, Joanne</creator><creator>Brehmer, Bernhard</creator><creator>Abdunnur, Rudi</creator><creator>Loertzer, Hagen</creator><creator>Ulm, Kurt</creator><creator>Hübner, Wilhelm</creator><creator>Bauer, Ricarda M.</creator><creator>Haferkamp, Axel</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7872-5496</orcidid></search><sort><creationdate>20181001</creationdate><title>The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?</title><author>Hüsch, Tanja ; Kretschmer, Alexander ; Thomsen, Frauke ; Kronlachner, Dominik ; Kurosch, Martin ; Obaje, Alice ; Anding, Ralf ; Kirschner-Hermanns, Ruth ; Pottek, Tobias ; Rose, Achim ; Olianas, Roberto ; Lusuardi, Lukas ; Friedl, Alexander ; Homberg, Roland ; Pfitzenmaier, Jesco ; Queissert, Fabian ; Naumann, Carsten M. ; Schweiger, Josef ; Wotzka, Carola ; Nyarangi-Dix, Joanne ; Brehmer, Bernhard ; Abdunnur, Rudi ; Loertzer, Hagen ; Ulm, Kurt ; Hübner, Wilhelm ; Bauer, Ricarda M. ; Haferkamp, Axel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-697443928861c8abcbc1f0c241ed8108aee4622f017e7ff9eae813c30506b6423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Chi-Square Distribution</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Nephrology</topic><topic>Oncology</topic><topic>Operative Time</topic><topic>Original Article</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Quality of Life</topic><topic>Retrospective Studies</topic><topic>Suburethral Slings - adverse effects</topic><topic>Suburethral Slings - classification</topic><topic>Treatment Outcome</topic><topic>Urinary incontinence</topic><topic>Urinary Incontinence, Stress - therapy</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hüsch, Tanja</creatorcontrib><creatorcontrib>Kretschmer, Alexander</creatorcontrib><creatorcontrib>Thomsen, Frauke</creatorcontrib><creatorcontrib>Kronlachner, Dominik</creatorcontrib><creatorcontrib>Kurosch, Martin</creatorcontrib><creatorcontrib>Obaje, Alice</creatorcontrib><creatorcontrib>Anding, Ralf</creatorcontrib><creatorcontrib>Kirschner-Hermanns, Ruth</creatorcontrib><creatorcontrib>Pottek, Tobias</creatorcontrib><creatorcontrib>Rose, Achim</creatorcontrib><creatorcontrib>Olianas, Roberto</creatorcontrib><creatorcontrib>Lusuardi, Lukas</creatorcontrib><creatorcontrib>Friedl, Alexander</creatorcontrib><creatorcontrib>Homberg, Roland</creatorcontrib><creatorcontrib>Pfitzenmaier, Jesco</creatorcontrib><creatorcontrib>Queissert, Fabian</creatorcontrib><creatorcontrib>Naumann, Carsten M.</creatorcontrib><creatorcontrib>Schweiger, Josef</creatorcontrib><creatorcontrib>Wotzka, Carola</creatorcontrib><creatorcontrib>Nyarangi-Dix, Joanne</creatorcontrib><creatorcontrib>Brehmer, Bernhard</creatorcontrib><creatorcontrib>Abdunnur, Rudi</creatorcontrib><creatorcontrib>Loertzer, Hagen</creatorcontrib><creatorcontrib>Ulm, Kurt</creatorcontrib><creatorcontrib>Hübner, Wilhelm</creatorcontrib><creatorcontrib>Bauer, Ricarda M.</creatorcontrib><creatorcontrib>Haferkamp, Axel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>World journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hüsch, Tanja</au><au>Kretschmer, Alexander</au><au>Thomsen, Frauke</au><au>Kronlachner, Dominik</au><au>Kurosch, Martin</au><au>Obaje, Alice</au><au>Anding, Ralf</au><au>Kirschner-Hermanns, Ruth</au><au>Pottek, Tobias</au><au>Rose, Achim</au><au>Olianas, Roberto</au><au>Lusuardi, Lukas</au><au>Friedl, Alexander</au><au>Homberg, Roland</au><au>Pfitzenmaier, Jesco</au><au>Queissert, Fabian</au><au>Naumann, Carsten M.</au><au>Schweiger, Josef</au><au>Wotzka, Carola</au><au>Nyarangi-Dix, Joanne</au><au>Brehmer, Bernhard</au><au>Abdunnur, Rudi</au><au>Loertzer, Hagen</au><au>Ulm, Kurt</au><au>Hübner, Wilhelm</au><au>Bauer, Ricarda M.</au><au>Haferkamp, Axel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?</atitle><jtitle>World journal of urology</jtitle><stitle>World J Urol</stitle><addtitle>World J Urol</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>36</volume><issue>10</issue><spage>1657</spage><epage>1662</epage><pages>1657-1662</pages><issn>0724-4983</issn><eissn>1433-8726</eissn><abstract>Purpose To compare the efficacy and perioperative complications of the AdVanceXP with the original AdVance male sling. Methods We retrospectively enrolled 109 patients with an AdVance and 185 patients with an AdVanceXP male sling. The baseline characteristics and complication rates were analyzed retrospectively. Functional outcome and quality of life were evaluated prospectively by standardized, validated questionnaires. The Chi 2 -test for categorical and Mann–Whitney U test for continuous variables were performed to identify heterogeneity between the groups. Results Regarding operation time, there was no significant difference between the slings ( p  = 0.146). The complication rates were comparable in both groups except for postoperative urinary retention. This occurred significantly more often in patients with the AdVanceXP ( p  = 0.042). During follow-up, no differences could be identified regarding ICIQ-SF, PGI or I-QoL or number of pad usage. Conclusions The AdVance and AdVanceXP are safe and effective treatment options for male stress urinary incontinence. However, the innovations of the AdVanceXP sling did not demonstrate a superiority over the original AdVance sling regarding functional outcome.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>29728764</pmid><doi>10.1007/s00345-018-2316-5</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-7872-5496</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0724-4983
ispartof World journal of urology, 2018-10, Vol.36 (10), p.1657-1662
issn 0724-4983
1433-8726
language eng
recordid cdi_proquest_miscellaneous_2035242476
source MEDLINE; SpringerNature Journals
subjects Aged
Chi-Square Distribution
Follow-Up Studies
Humans
Male
Medicine
Medicine & Public Health
Nephrology
Oncology
Operative Time
Original Article
Patients
Prospective Studies
Quality of Life
Retrospective Studies
Suburethral Slings - adverse effects
Suburethral Slings - classification
Treatment Outcome
Urinary incontinence
Urinary Incontinence, Stress - therapy
Urology
title The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T15%3A50%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20AdVance%20and%20AdVanceXP%20male%20sling%20in%20urinary%20incontinence:%20is%20there%20a%20difference?&rft.jtitle=World%20journal%20of%20urology&rft.au=H%C3%BCsch,%20Tanja&rft.date=2018-10-01&rft.volume=36&rft.issue=10&rft.spage=1657&rft.epage=1662&rft.pages=1657-1662&rft.issn=0724-4983&rft.eissn=1433-8726&rft_id=info:doi/10.1007/s00345-018-2316-5&rft_dat=%3Cproquest_cross%3E2035242476%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=220275919&rft_id=info:pmid/29728764&rfr_iscdi=true